Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Tyrosine kinase inhibitors: new hope with new challenges

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: HO, Han Kiat (National University of Singapore, Department of Pharmacy, Singapore, Singapore)
  • Abstract:

    The advent of molecular targeted therapy (most notably the tyrosine kinase inhibitors) for cancer treatment generates a distinct range of adverse effects that are different from conventional chemotherapy and are mechanistically unpredictable. In particularly, hepatotoxicity has been observed frequently, leading to black box warning labels being..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses